Your browser doesn't support javascript.
loading
Current status and research interests of the diagnosis and treatment of cholestatic liver disease / 临床肝胆病杂志
Journal of Clinical Hepatology ; (12): 241-246, 2019.
Article em Zh | WPRIM | ID: wpr-778881
Biblioteca responsável: WPRO
ABSTRACT
Cholestatic liver disease (CSLD) is a group of liver diseases which can cause cholestasis and has a complex etiology. Its pathogenesis remains unclear, and there are still no effective treatment measures. In the recent decade, new achievements have been made on various aspects of CSLD, which provides more help to accurate diagnosis and treatment and reflects many pending issues which need further research. This article introduces the research advances and problems in CSLD from the following six aspects: the “ascending” pathophysiology of CSLD, mechanisms of cholestasis-induced liver fibrosis and related management measures, association of enterohepatic circulation and intestinal microbiota with CSLD, pathogenesis and diagnosis/treatment of drug-induced cholestasis, pathogenesis and management of liver failure-associated cholestasis, and research advances in treatment targets and drug research and development for CSLD.
Palavras-chave
Texto completo: 1 Índice: WPRIM Tipo de estudo: Diagnostic_studies Idioma: Zh Revista: Journal of Clinical Hepatology Ano de publicação: 2019 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Tipo de estudo: Diagnostic_studies Idioma: Zh Revista: Journal of Clinical Hepatology Ano de publicação: 2019 Tipo de documento: Article